
-
Forest seal swoop for Ipswich's Hutchinson
-
Haaland fires Man City to opening win at Wolves
-
Brazil's Bolsonaro leaves house arrest for medical exams
-
Mikautadze gets Lyon off to winning start in Ligue 1 at Lens
-
Fires keep burning in western Spain as army is deployed
-
Captain Wilson scores twice as Australia stun South Africa
-
Thompson eclipses Lyles and Hodgkinson makes stellar comeback
-
Spurs get Frank off to flier, Sunderland win on Premier League return
-
Europeans try to stay on the board after Ukraine summit
-
Richarlison stars as Spurs boss Frank seals first win
-
Hurricane Erin intensifies to 'catastrophic' category 5 storm in Caribbean
-
Thompson beats Lyles in first 100m head-to-head since Paris Olympics
-
Brazil's Bolsonaro leaves house arrest for court-approved medical exams
-
Hodgkinson in sparkling track return one year after Olympic 800m gold
-
Air Canada grounds hundreds of flights over cabin crew strike
-
Hurricane Erin intensifies to category 4 storm as it nears Caribbean
-
Championship leader Marc Marquez wins sprint at Austrian MotoGP
-
Newcastle held by 10-man Villa after Konsa sees red
-
Semenyo says alleged racist abuse at Liverpool 'will stay with me forever'
-
In high-stakes summit, Trump, not Putin, budges
-
Pakistan rescuers recover bodies after monsoon rains kill 340
-
Hurricane Erin intensifies to category 3 storm as it nears Caribbean
-
Ukrainians see 'nothing' good from Trump-Putin meeting
-
Pakistan rescuers recover bodies after monsoon rains kill 320
-
Bob Simpson: Australian cricket captain and influential coach
-
Air Canada flight attendants strike over pay, shutting down service
-
Air Canada set to shut down over flight attendants strike
-
Majority of Americans think alcohol bad for health: poll
-
Hurricane Erin intensifies in Atlantic, eyes Caribbean
-
Louisiana sues Roblox game platform over child safety
-
Kildunne confident Women's Rugby World Cup 'heartbreak' can inspire England to glory
-
Arsenal 'digging for gold' as title bid starts at new-look Man Utd
-
El Salvador to jail gang suspects without trial until 2027
-
Alcaraz survives to reach Cincy semis as Rybakina topples No. 1 Sabalenka
-
Trump hails Putin summit but no specifics on Ukraine
-
El Salvador extends detention of suspected gang members
-
Scotland's MacIntyre fires 64 to stay atop BMW Championship
-
Colombia's Munoz fires 59 to grab LIV Golf Indy lead
-
Alcaraz survives Rublev to reach Cincy semis as Rybakina topples No. 1 Sabalenka
-
Trump offers warm welcome to Putin at high-stakes summit
-
Semenyo racist abuse at Liverpool shocks Bournemouth captain Smith
-
After repeated explosions, new test for Musk's megarocket
-
Liverpool strike late to beat Bournemouth as Jota remembered in Premier League opener
-
Messi expected to return for Miami against Galaxy
-
Made-for-TV pageantry as Trump brings Putin in from cold
-
Coman bids farewell to Bayern before move to Saudi side Al Nassr
-
Vietnamese rice grower helps tackle Cuba's food shortage
-
Trump, Putin shake hands at start of Alaska summit
-
Coman bids farewell to Bayern ahead of Saudi transfer
-
Liverpool honour Jota in emotional Premier League curtain-raiser

Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
O.Bulka--BTB